Pembrolizumab in Locally Advanced Sinonasal Carcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pembrolizumab in Locally Advanced Sinonasal Carcinoma — Stella

Recruiting

Back to Sinonasal Undifferentiated Carcinoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Italy

Istituti Clinici Scientifici Maugeri, Pavia, Lombardy

Key details

Phase

Safety & dosing

Sponsor

Istituti Clinici Scientifici Maugeri SpA

Collaborators

Merck Sharp & Dohme LLC

Enrollment target

~28 participants

Started

December 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov